The CT-derived functional imaging software provides lung diagnostics without the need for contrast dye, which could benefit up to 30% of patients allergic to dye or with dye restrictions.
The CT-derived functional imaging software provides lung diagnostics without the need for contrast dye, which could benefit up to 30% of patients allergic to dye or with dye restrictions.
Read More
The clearance broadens the applicability of the AlphaVac F1885 System in the non-surgical removal of thrombi or emboli from the venous vasculature.
Read More
The trend of hospitalizing low-risk PE patients continues despite evidence supporting safe outpatient care, according to a new analysis.
Read More
New research shows an endovascular catheter, recently approved by the FDA and already shown to be effective in reducing blockages in lung arteries, also reduces blockages in the smaller segmental pulmonary artery branches.
Read More
A trial emulation study of veterans with COVID-19 found that the use of the antiviral nirmatrelvir–ritonavir (Paxlovid) was not effective for reducing the risk for many post-COVID-19 conditions.
Read More
Despite advancements, a Michigan Medicine study finds that the death rate for pulmonary embolism remains high and unchanged in recent years—more often killing men, Black patients, and those from rural areas.
Read More
Modern blood-thinning drugs (known as NOACs) reduce the risk of serious bleeding by up to 45% compared to the traditional drug warfarin in the treatment of blood clots in the lungs and legs, according to a new long-term study.
Read More
ED patients with congestive heart failure and dyspnea are less likely to be tested for pulmonary embolism when their ED forms specifically mention CHF instead of “shortness of breath.”
Read More
A modeling study suggests that continuing anticoagulation therapy indefinitely, which is recommended in all patients with a first unprovoked venous thromboembolism, has little chance of improving life expectancy and is unlikely to ever be cost-effective.
Read More
A new study suggests CT results alone may not confer as much risk as traditionally thought—a finding that will come as a surprise to most emergency physicians, according to one of the study’s authors.
Read More
Sleeping less than five hours a night is associated with a 74% raised likelihood of developing peripheral artery disease (PAD) compared with seven to eight hours of sleep.
Read More
Sleeping less than five hours a night is associated with a 74% greater likelihood of developing peripheral artery disease (PAD) compared with seven to eight hours of sleep, according to new research.
Read More
Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in women, according new research that highlights the biological, clinical and societal reasons why the condition may be missed in women, who respond less well to treatment and have worse clinical outcomes.
Read More
The study found individuals with long COVID were more likely to experience pulmonary embolism, asthma, and chronic obstructive pulmonary disease.
Read More
Rapid RV/LV is designed to help physicians quickly assess the severity of a suspected pulmonary embolism.
Read More
Obese women who use oral contraceptives containing estrogen and progestin have a 24-fold increased risk of venous thromboembolism (VTE) compared with non-obese women not using the drugs, according to a review paper published in ESC Heart Failure.
Read More
People who suffer from obstructive sleep apnea are at an increased risk of cancer and emboli, and a decline in cognitive functions.
Read More
COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure, and the vaccines were not associated with an increased risk of worsening heart failure, venous thromboembolism or myocarditis in heart failure patients.
Read More
Treatment of critically ill COVID-19 patients with full-dose anticoagulation lowers the risk of venous and arterial clotting complications by 44% compared with the standard dose, according to research presented at ESC Congress 2022.
Read More
Circulating antiphospholipid antibodies which target a person’s own organs and systems, can also be activated in response to viral infections and may play a role with COVID-19 blood clots.
Read More
There is a slightly elevated risk of intracranial thrombosis events following vaccination with the AstraZeneca ChAdOx1-S COVID vaccine, according to two new studies published in Plos Medicine
Read More
A group of researchers identified “rogue antibodies” that correlate with severe illness and may help explain mechanisms associated with severe blood clotting.
Read More
Disulfiram — an FDA-approved drug that has been in clinical use for more than 70 years — protected against lung injury and the risk of blood clots in severe COVID-19.
Read More
Binge-watching TV for four hours a day or more is associated with a 35% higher risk of blood clots compared with less than 2.5 hours, a new observational study reports.
Read More
